TABLE 2.
Primer | Sequence | Target | PCR conditions (°C, s)a
|
PCR product (bp) | Source or reference | Positive controlb (reference) | ||
---|---|---|---|---|---|---|---|---|
Denaturing | Annealing | Extension | ||||||
cdtI-fc | 5′-TGG TGA GAA TCG GAA CTG-3′ | cdt-IA | 94, 30 | 51, 60 | 72, 60 | 418 | This study | 6468/62 (22) |
cdtI-rc | 5′-CAT TCC ATC AGG TTT GTC-3′ | |||||||
cdtII-fd | 5′-AAT CCC TAT CCC TGA ACC-3′ | cdt-IIA | 94, 30 | 52, 60 | 72, 60 | 542 | This study | 9142/88 (20) |
cdtII-rd | 5′-GTT CTA TTG GCT GTG GTG-3′ | |||||||
cdtIII-f | 5′-AAACAGGACGGTAATAATGACTAATA-3′ | cdt-III | 94, 30 | 54, 60 | 72, 180e | 2,230 | 4 | 1404 (19) |
cdtIII-r | 5′-GTGATCTCCTTCCATGAAAATATAGT-3′ | Complete sequence | ||||||
CDT-IVs | 5′-CCTGATGGTTCAGGAGGCTGGTTC-3′ | cdt-IVB | 94, 60 | 55, 60 | 72, 60e | 350 | 24 | M375/95 (this study) |
CDT-IVas | 5′-TTGCTCCAGAATCTATACCT-3′ | |||||||
c338f | 5′-AGC ATT AAA TAA AAG CAC GA-3′ | cdt-VA | 94, 30 | 52, 60 | 72, 60 | 1,329 | 11 | 493/89 (11) |
c2135r | 5′-TAC TTG CTG TGG TCT GCT AT-3′ | |||||||
c1309f | 5′-AGC ACC CGC AGT ATC TTT GA-3′ | cdt-VB | 94, 30 | 52, 60 | 72, 60 | 1,363 | 11 | 493/89 (11) |
c2166r | 5′-AGC CTC TTT TAT CGT CTG GA-3′ | |||||||
P105 | 5′-GTC AAC GAA CAT TAG ATT AT-3′ | cdt-VC | 94, 30 | 49, 60 | 72, 60 | 748 | 11 | 493/89 (11) |
c2767r | 5′-ATG GTC ATG CTT TGT TAT AT-3′ | |||||||
c338f | 5′-AGC ATT AAA TAA AAG CAC GA-3′ | cdt-V | 94, 30 | 51, 60 | 72, 180e | 2,449 | 11 | 493/89 (11) |
c2767r | 5′-ATG GTC ATG CTT TGT TAT AT-3′ | Complete sequence |
PCRs were performed with 25-μl volumes as previously described (8) and included 30 cycles followed by a final extension of 5 min at 72°C unless otherwise stated.
The E. coli control strains 6468/62 (serotype O86:H34, allele cdt-I+), 9142/88 (O128:H−, cdt-II+), and 1404 (O78:H?, cdt-III+) were provided by D. A. Scott (University of Maryland School of Medicine, Baltimore, Md.), C. L. Pickett (University of Kentucky Medical Center, Lexington, Ky.) and E. Oswald (Ecole Nationale Veterinaire, Toulouse, France), respectively. E. coli strain M375/95 (O75, cdt-IV+) was isolated from a patient with a urinary tract infection (M. Bielaszewska, unpublished data), and the presence of cdt-IVB was verified by sequencing. E. coli strain C600 was a negative control in all PCRs.
The primers for the detection of cdt-IA were designed from the published cdt-I sequence (GenBank accession number U03293) (22).
The primers for the detection of cdt-IIA were designed from the published cdt-II sequence (GenBank accession number U04208) (20).
The final extension was performed at 72°C for 10 min.